A novel optical biosensor for the early diagnosis of sepsis and severe Covid-19: the PROUD study

A novel optical biosensor for the early diagnosis of sepsis and severe Covid-19: the PROUD study

Abstract Background The accuracy of a new optical biosensor (OB) point-of-care device for the detection of severe infections is studied. Methods The OB emits different wavelengths and outputs information associated with heart rate, pulse oximetry, levels of nitric oxide and kidney function. At the f...

Full description

Bibliographic Details
Main Authors: Sarantia Doulou, Konstantinos Leventogiannis, Maria Tsilika, Matthew Rodencal, Konstantina Katrini, Nikolaos Antonakos, Miltiades Kyprianou, Emmanouil Karofylakis, Athanassios Karageorgos, Panagiotis Koufargyris, Gennaios Christopoulos, George Kassianidis, Kimon Stamatelopoulos, Robert Newberry, Evangelos J. Giamarellos-Bourboulis
Format: Article
Language:English
Published: BMC 2020-11-01
Series:BMC Infectious Diseases
Subjects:
Sepsis
Optical biosensor
Diagnosis
Severity
COVID-19
SARS-CoV-2
Online Access:http://link.springer.com/article/10.1186/s12879-020-05607-1

Internet

http://link.springer.com/article/10.1186/s12879-020-05607-1

Similar Items